Pain Relief for Birth Control Implants Insertion

Topical Lidocaine-prilocaine Cream Versus Lidocaine Infiltration for Pain Relief During Insertion of Subcutaneous Birth Control Implants : A Randomized Controlled Trial

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03187392

Enrollment

144

Registered

2017-06-15

Start date

2017-06-12

Completion date

2018-09-18

Last updated

2018-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception, Lidocaine

Brief summary

The aim of our study is to compare the analgesic effect of topical application of lidocaine-prilocaine cream and lidocaine infiltration during insertion of birth control implants

Interventions

DRUGLidocaine Injectable Product

3 cm of Lidocaine- will be injected subcutaneous for 5 minutes before insertion of subcutaneous birth control implant

DRUGLidocaine Topical Cream [LMX]

3 mg of Lidocaine- will be applied to skin for 5 minutes before insertion of subcutaneous birth control implant

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* female want use subcutaneous birth control

Exclusion criteria

* previous scar at side of insertion

Design outcomes

Primary

Measure	Time frame
Mean pain score during insertion of implant	10 minutes

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026